ReviewBone reports2026
The natural history of osteogenesis imperfecta: a systematic review.
Review in Bone reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteogenesis imperfecta (OI) is a rare, heritable condition characterised by bone fragility, varied manifestations, and phenotypic heterogeneity. Understanding its natural history is essential for anticipating clinical needs. This systematic review collated literature on OI's natural history, focussing on diagnosis, signs, symptoms, and events (SSEs), and mortality. MEDLINE, Embase, and Embase Conference Abstracts were searched on March 24, 2024. Longitudinal (≥5 years follow-up) and cross-sectional studies which analysed outcomes by age were included, irrespective of interventions, due to treatment variability in OI. Sixty-six studies were included. Age of diagnosis varied widely; severe OI was typically diagnosed in early childhood, whereas milder types showed greater variability. SSEs manifest across ages. Some SSEs progress rapidly in childhood (e.g. scoliosis and bone deformities), whereas others (e.g. cardiac, ocular, auditory, and joint issues) emerge in adulthood, often earlier and more commonly than in the general population. Severe phenotypes may be associated with earlier onset and greater symptom severity than milder types. Fractures may be most frequent during childhood and adolescence but continue into adulthood, with limb fractures most reported. Aging, pregnancy, and menopause may increase the risk of hip, spine, and femur fractures. Life expectancy appears reduced by an average 9.5 years in men and 7.1 in women versus the general population. Leading causes of mortality include OI-related complications, cardiovascular and respiratory issues, and fracture-related trauma. The heterogeneous, progressive nature of SSEs supports the need for tailored, multidisciplinary long-term care. However, substantial evidence gaps and methodological inconsistencies limit comparability, highlighting the need for further evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.